AJP - GI AJP: Advances in Physiology Education
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 290: G923-G932, 2006. First published December 15, 2005; doi:10.1152/ajpgi.00490.2005
0193-1857/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/5/G923    most recent
00490.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (43)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zollner, G.
Right arrow Articles by Trauner, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zollner, G.
Right arrow Articles by Trauner, M.

LIVER AND BILIARY TRACT

Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-{alpha}/beta in the adaptive response to bile acids

Gernot Zollner,1 Martin Wagner,1 Tarek Moustafa,1 Peter Fickert,1 Dagmar Silbert,1 Judith Gumhold,1 Andrea Fuchsbichler,2 Emina Halilbasic,1 Helmut Denk,2 Hanns-Ulrich Marschall,3 and Michael Trauner1

1Laboratory of Experimental and Molecular Hepatology, Division of Gastroenterology and Hepatology, Department of Internal Medicine, and 2Department of Pathology, Medical University Graz, Graz, Austria; and 3Karolinska University Hospital Huddinge, Stockholm, Sweden.

Submitted 17 October 2005 ; accepted in final form 9 December 2005

The bile acid receptor farnesoid X receptor (FXR) is a key regulator of hepatic defense mechanisms against bile acids. A comprehensive study addressing the role of FXR in the coordinated regulation of adaptive mechanisms including biosynthesis, metabolism, and alternative export together with their functional significance is lacking. We therefore fed FXR knockout (FXR–/–) mice with cholic acid (CA) and ursodeoxycholic acid (UDCA). Bile acid synthesis and hydroxylation were assessed by real-time RT-PCR for cytochrome P-450 (Cyp)7a1, Cyp3a11, and Cyp2b10 and mass spectrometry-gas chromatography for determination of bile acid composition. Expression of the export systems multidrug resistance proteins (Mrp)4–6 in the liver and kidney and the recently identified basoalteral bile acid transporter, organic solute transporter (Ost-{alpha}/Ost-beta), in the liver, kidney, and intestine was also investigated. CA and UDCA repressed Cyp7a1 in FXR+/+ mice and to lesser extents in FXR–/– mice and induced Cyp3a11 and Cyp2b10 independent of FXR. CA and UDCA were hydroxylated in both genotypes. CA induced Ost-{alpha}/Ost-beta in the liver, kidney, and ileum in FXR+/+ but not FXR–/– mice, whereas UDCA had only minor effects. Mrp4 induction in the liver and kidney correlated with bile acid levels and was observed in UDCA-fed and CA-fed FXR–/– animals but not in CA-fed FXR+/+ animals. Mrp5/6 remained unaffected by bile acid treatment. In conclusion, we identified Ost-{alpha}/Ost-beta as a novel FXR target. Absent Ost-{alpha}/Ost-beta induction in CA-fed FXR–/– animals may contribute to increased liver injury in these animals. The induction of bile acid hydroxylation and Mrp4 was independent of FXR but could not counteract liver toxicity sufficiently. Limited effects of UDCA on Ost-{alpha}/Ost-beta may jeopardize its therapeutic efficacy.

nuclear receptors; cholestrasis; liver; kidney; intestine; farnesoid X receptor; cholic acid; ursodeoxycholic acid



Address for reprint requests and other correspondence: M. Trauner, Laboratory of Experimental and Molecular Hepatology, Div. of Gastroenterology and Hepatology, Dept. of Internal Medicine, Medical Univ. Graz, Auenbruggerplatz 15, Graz A-8036, Austria (e-mail: michael.trauner{at}meduni-graz.at)




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
S. Nishida, J. Ozeki, and M. Makishima
Modulation of Bile Acid Metabolism by 1{alpha}-Hydroxyvitamin D3 Administration in Mice
Drug Metab. Dispos., October 1, 2009; 37(10): 2037 - 2044.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
I. L. Csanaky, L. M. Aleksunes, Y. Tanaka, and C. D. Klaassen
Role of hepatic transporters in prevention of bile acid toxicity after partial hepatectomy in mice
Am J Physiol Gastrointest Liver Physiol, September 1, 2009; 297(3): G419 - G433.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
P. Martinez-Fernandez, L. Hierro, P. Jara, and L. Alvarez
Knockdown of ATP8B1 expression leads to specific downregulation of the bile acid sensor FXR in HepG2 cells: effect of the FXR agonist GW4064
Am J Physiol Gastrointest Liver Physiol, May 1, 2009; 296(5): G1119 - G1129.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
K. Klein, G. A. Kullak-Ublick, M. Wagner, M. Trauner, and J. J. Eloranta
Hepatocyte nuclear factor-4{alpha} and bile acids regulate human concentrative nucleoside transporter-1 gene expression
Am J Physiol Gastrointest Liver Physiol, April 1, 2009; 296(4): G936 - G947.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
P. Lefebvre, B. Cariou, F. Lien, F. Kuipers, and B. Staels
Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation
Physiol Rev, January 1, 2009; 89(1): 147 - 191.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
O. Renner, S. Harsch, A. Strohmeyer, S. Schimmel, and E. F. Stange
Reduced ileal expression of OST{alpha}-OST{beta} in non-obese gallstone disease
J. Lipid Res., September 1, 2008; 49(9): 2045 - 2054.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H. Zaher, H. E. M. zu Schwabedissen, R. G. Tirona, M. L. Cox, L. A. Obert, N. Agrawal, J. Palandra, J. L. Stock, R. B. Kim, and J. A. Ware
Targeted Disruption of Murine Organic Anion-Transporting Polypeptide 1b2 (oatp1b2/Slco1b2) Significantly Alters Disposition of Prototypical Drug Substrates Pravastatin and Rifampin
Mol. Pharmacol., August 1, 2008; 74(2): 320 - 329.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
N. Ballatori, F. Fang, W. V. Christian, N. Li, and C. L. Hammond
Ost{alpha}-Ost{beta} is required for bile acid and conjugated steroid disposition in the intestine, kidney, and liver
Am J Physiol Gastrointest Liver Physiol, July 1, 2008; 295(1): G179 - G186.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
M. Wagner, G. Zollner, P. Fickert, J. Gumhold, D. Silbert, A. Fuchsbichler, J. S. Gujral, K. Zatloukal, H. Denk, H. Jaeschke, et al.
Hepatobiliary Transporter Expression in Intercellular Adhesion Molecule 1 Knockout and Fas Receptor-Deficient Mice after Common Bile Duct Ligation Is Independent of the Degree of Inflammation and Oxidative Stress
Drug Metab. Dispos., September 1, 2007; 35(9): 1694 - 1699.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
A.-Q. Sun, N. Balasubramaniyan, K. Xu, C. J. Liu, V. M. Ponamgi, H. Liu, and F. J. Suchy
Protein-protein interactions and membrane localization of the human organic solute transporter
Am J Physiol Gastrointest Liver Physiol, June 1, 2007; 292(6): G1586 - G1593.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
K. Mori, P. E. Blackshear, E. K. Lobenhofer, J. S. Parker, D. P. Orzech, J. H. Roycroft, K. L. Walker, K. A. Johnson, T. A. Marsh, R. D. Irwin, et al.
Hepatic Transcript Levels for Genes Coding for Enzymes Associated with Xenobiotic Metabolism are Altered with Age
Toxicol Pathol, February 1, 2007; 35(2): 242 - 251.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. W. Joyce, E. M. Wagner, F. Basso, M. J. Amar, L. A. Freeman, R. D. Shamburek, C. L. Knapper, J. Syed, J. Wu, B. L. Vaisman, et al.
ABCA1 Overexpression in the Liver of LDLr-KO Mice Leads to Accumulation of Pro-atherogenic Lipoproteins and Enhanced Atherosclerosis
J. Biol. Chem., November 3, 2006; 281(44): 33053 - 33065.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. L. Boyer, M. Trauner, A. Mennone, C. J. Soroka, S.-Y. Cai, T. Moustafa, G. Zollner, J. Y. Lee, and N. Ballatori
Upregulation of a basolateral FXR-dependent bile acid efflux transporter OST{alpha}-OSTbeta in cholestasis in humans and rodents
Am J Physiol Gastrointest Liver Physiol, June 1, 2006; 290(6): G1124 - G1130.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.